Intra-Cellular Therapies, Inc. (ITCI)
NASDAQ: ITCI · IEX Real-Time Price · USD
69.20
-0.52 (-0.75%)
At close: Mar 28, 2024, 4:00 PM
69.00
-0.20 (-0.29%)
After-hours: Mar 28, 2024, 7:06 PM EDT

Intra-Cellular Therapies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2011
Net Income
-139.67-256.26-284.13-227.01-147.72-155.13-97.77-116.43-104.79-30.69
Upgrade
Depreciation & Amortization
0.530.660.530.530.480.370.210.20.140.03
Upgrade
Share-Based Compensation
52.9243.134.4824.3320.9817.5914.8314.9311.074.02
Upgrade
Other Operating Activities
-37.98-57.69-10.43-27.92-1.72192.2410.04-8.73.84
Upgrade
Operating Cash Flow
-124.2-270.19-259.54-230.07-127.98-118.17-80.49-91.26-102.28-22.81
Upgrade
Capital Expenditures
-0.27-0.78-0.33-0.27-0.7-0.39-0.72-0.05-0.86-0.01
Upgrade
Change in Investments
105.81-127.6280.67-480.03178.14135.03-91.9992.31-360.92-66.72
Upgrade
Investing Cash Flow
105.54-128.37280.34-480.3177.44134.64-92.7292.26-361.78-66.73
Upgrade
Share Issuance / Repurchase
17.81455.1611.52664.183.240.69162.360.48450.65116.46
Upgrade
Other Financing Activities
---------0.76-0.75
Upgrade
Financing Cash Flow
17.81455.1611.52664.183.240.69162.360.48449.89115.72
Upgrade
Net Cash Flow
-0.8556.632.32-46.1952.6917.16-10.851.48-14.1726.17
Upgrade
Free Cash Flow
-124.47-270.96-259.87-230.34-128.68-118.56-81.22-91.31-103.14-22.82
Upgrade
Free Cash Flow Margin
-26.80%-108.25%-310.10%-1009.69%-212303.69%--33036.22%-27609.81%-112889.72%-3952.69%
Upgrade
Free Cash Flow Per Share
-1.30-2.88-3.20-3.27-2.33-2.17-1.76-2.11-2.86-0.80
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).